About this trial
Plant-based diets are increasingly adopted for health and environmental reasons, but they are associated with lower bone mineral density, higher fracture risk, and elevated bone turnover markers, particularly in women. These effects are partly explained by lower intakes of calcium and zinc, and higher concentrations of phytates and oxalates, substances that inhibit mineral absorption from plant foods. Evidence-based dietary strategies to support bone health in vegan populations beyond supplementation remain limited.
Fermented plant-based foods may help address this gap through two complementary mechanisms: first, by delivering live microorganisms that beneficially modulate gut microbiota and promote the production of short-chain fatty acids, which support mineral absorption and reduce bone resorption, and second, by reducing antinutritional factors such as phytates during microbial fermentation, thereby improving mineral bioavailability.
This study investigates whether the daily consumption of fermented plant-based foods, specifically lacto-fermented vegetables, calcium-fortified plant-based yogurt alternatives with live cultures, and Rhizopus-fermented tempeh, reduces bone resorption and improves calcium metabolism in premenopausal women following a vegan diet. Participants will follow each dietary condition (fermented or matched non-fermented control foods) for 12 weeks in randomized order, separated by an 8-week washout period. Blood, urine, and stool samples are collected at each study visit to assess bone turnover markers, gut microbiota composition, short-chain fatty acid production, inflammatory markers, and a range of metabolic and nutritional parameters.
Eligibility criteria
Qualifiers
Female, aged 28-43years.
Body mass index (BMI) between 18.5 and 24.9 kg/m².
Premenopausal, with regular menstrual cycles. *
Adherence to a vegan diet for ≥1 year, confirmed by questionnaire.
Disqualifiers
Chronic diseases or conditions affecting bone metabolism (e.g., osteoporosis, thyroid disorders, chronic kidney and liver disease, menstrual cycles disorders affecting bone health, conditions associated with malabsorption).
History of diagnosed eating disorders.
Chronic inflammatory or gastrointestinal diseases (e.g., IBD, celiac disease).
Recent antibiotic use (within 3 months prior to screening).
Trial design
Treatments tested in this trial
- Fermented Plant-Based Foods
- Non-Fermented Plant-Based Foods
Treatment groups
Sponsors and collaborators
Isabelle Herter-Aeberli
Lead sponsor
ETH Zurich
Sponsor institution
Swiss National Science Foundation
Collaborator
Philhuman Foundation
Collaborator
Czech Science Foundation
Collaborator
Charles University, Czech Republic
Collaborator